ALLERGENS FOOD, LOBSTER, IgE F80

The ALLERGENS FOOD, LOBSTER, IgE F80 is a lab‑certified home IgE test that detects and quantifies lobster‑specific immunoglobulin E (sIgE) antibodies in the blood to identify sensitisation to lobster. A trained phlebotomist collects a serum sample at your home across Dubai and the UAE, and the sample is analysed in accredited diagnostic laboratories to provide standardized, clinically meaningful results. Results help clinicians determine allergy risk, guide dietary avoidance, and advise on emergency preparedness such as carrying an epinephrine auto‑injector when indicated. The service combines clinical reliability with the convenience of home collection and secure digital reporting.

• Lobster-specific IgE (sIgE) — quantitative (kUA/L)
• Total IgE (where included by the laboratory)
• Allergen-specific IgE class/category (sensitisation class 0–6)
• Serum sample validity indicators (hemolysis/volume)

• After an immediate reaction to lobster or other shellfish (hives, swelling, wheeze, anaphylaxis)
• Repeated urticaria or gastrointestinal symptoms following lobster consumption
• When planning reintroduction or supervised food challenges under medical advice
• When there is a personal or strong family history of seafood allergy and uncertainty about sensitisation
• Prior to receiving medical clearance for travel or dining where lobster exposure is likely

• Quantitative, lab‑certified measurement of lobster-specific IgE for clinical decision making
• Convenient professional sample collection at home across Dubai and the UAE
• Secure digital report with standardised units and interpretation guidance
• Personalised follow‑up recommendations and referral options to allergists or dietitians
• Helps reduce unnecessary food avoidance and supports safe dietary planning

• Professional at‑home blood draw (venous serum sample) performed by an accredited phlebotomist
• No fasting required; ensure adequate hydration before collection
• Inform the collector and laboratory of recent immunotherapy or anti‑IgE biologic therapy (e.g., omalizumab) and current medications
• Valid Emirates ID or passport and signed consent for sample collection and testing